Fate Therapeutics Inc (FATE)

76.49 -0.06  -0.08% NASDAQ May 7, 20:00 USD
View Full Chart
Price Chart
View All FATE News

News

View All Events

Events

Date Type Description
08/05/2021 00:00 Earnings Results Q2 2021 Earnings Results
08/05/2021 17:30 Earnings Calls Q2 2021 Earnings Call
05/05/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/05/2021 17:00 EDT Earnings Calls Q1 2021 Earnings Call
02/24/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/24/2021 17:00 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 17:00 EST Earnings Calls Q3 2020 Earnings Call
11/05/2020 00:00 Earnings Results Q3 2020 Earnings Results
08/05/2020 17:30 EDT Earnings Calls Q2 2020 Earnings Call
08/05/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
  • URL: http://www.fatetherapeutics.com
  • Investor Relations URL: https://ir.fatetherapeutics.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
IDNA iShares Genomics Immnlgy & Hlthcr ETF 5.07%
SBIO ALPS Medical Breakthroughs ETF 4.28%
EAGB.NO Emerge ARK Genomics & Biotech ETF 3.47%
ARKG ARK Genomic Revolution ETF 3.37%
PJHRX PGIM Jennison Health Sciences R 2.03%
FRBRX Franklin Biotechnology Discovery R6 1.79%
HQL Tekla Life Sciences Investors 1.42%
PGRRX Pioneer Select Mid Cap Growth R 1.34%
USTCX USAA Science & Technology Class A 1.01%
FBIOX Fidelity® Select Biotechnology 0.99%
VTWG Vanguard Russell 2000 Growth ETF 0.46%
FSSNX Fidelity® Small Cap Index 0.26%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.